Creation
Draft
Initial
Detailed
Accepted
Adoption
Idea Description
Supplementary Information
Innovation 'Elevator Pitch':
Feeliom prevents anxiety & depression by helping people stay in touch. Our mobile app's unique Sensory Language tackles loneliness, enabling emotional expression without the need for words, and generates continuous insights into wellbeing using AI.
Overview of Innovation:
Feeliom is a mobile app that empowers people to intuitively express emotions through technology; without the need for words. It does so by emulating our sense of touch.

Touch plays a prominent role in sharing emotions. and has many positive effects on health. A gentle stroke can increase the release of oxytocin and serotonin, which improves wellbeing and positively regulates affection and social behaviour.
A science known as haptics lies at the intersection of touch and technology. By blending haptics with sound and visual feedback, Feeliom creates a tangible representation of how we feel that can be easily shared with others.

Not only does its patented Sensory Language create an immersive communication experience, Feeliom allows us to quantify and analyse a single emotion across over 10,000 data points.

This quantitative data is brought together with Artifical Intelligence (AI) to analyse feelings shared on a continuous basis. This enables Feeliom to contextualise emotions across the entire spectrum of one’s wellbeing; determining variance, trends and profundity of risk for mental health problems on a personalised basis.

These insights are subsequently used to help the individual gain a continuous understanding of their mental health/wellbeing, including recommendations for improvement, and to proactively connect them with the appropriate care: Whether that’s from family and friends, colleagues at work or healthcare professionals.



There are several modules within Feeliom that can be used to communicate emotions, enabling the app to gain an evermore well-rounded understanding of one’s state of mind. These lie in stark contrast to the verbal methods for sentiment analysis upon which most methods currently rely.

Feeliom will help to identify symptoms of stress, anxiety & depression and prevent them, however, all diagnoses must be carried out by a qualified professional. Patients may allow healthcare professionals to access their data in real-time, particularly in the case where the app plays a supportive, as opposed to a preventive role.

Specific Applications:

1. People with impaired verbal communication - such as those with learning disabilities or dementia - often face disproportionately higher rates of depression linked to loneliness. Feeliom overcomes this through touch.

2. An emerging body of evidence demonstrates that depression and physical disorders, including diabetes, are commonly comorbid making it an increasingly important clinical and global health issue.
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
Similar Content2
Innovation 'Elevator Pitch':
The MyCognition App is co-designed with patients and trialled with academics to monitor, prevent and treat mental well-being by measuring, monitoring and improving cognitive health.
Overview of Innovation:
Cognitive functioning (attention, episodic memory, executive function, working memory and processing speed) are tightly linked with mental health.  Research shows that cognitive deficits are significant predictors and major risk factors for mental illness e.g. depression, anxiety and stress. Poor cognitive health has a negative impact on our emotions, our coping strategies and tendency to ruminate and catastrophise. Alternatively, robust cognitive health contributes to building good psychological resilience, self-management and control, which are major protective factors for prevalent mental diseases. Cognition deficit affects all ages. It is manifest in young children and adolescents affecting school performance and mental well-being. It is also prevalent in preretirement populations where patients present with unexplained symptoms often categorised as psychosomatic.


MyCognition App provides digitally delivered assessment, cognitive training, coaching and behavioural change programmes. It is an easy to use and patient friendly app that can be used with any device. It is a fun and engaging App designed for all age groups for use in everyday settings.
The App has three programmes:
  1. MyCQ™ – a five-domain, 15 minute, cognitive assessment tool based on a clinically validated version.
  2. AquaSnap™ – a fun cognitive training tool, programmed by MyCQ to train all five cognitive domains. The training is personalised, designed to improve and boost an individual’s cognition where they have greatest need.
  3. A digitally delivered coaching programme to raise awareness of cognitive health and to educate and train people in healthy habits encouraging positive behavioural change.
The MyCognition App is a resource which patients can use remotely in their own homes, in residential stay or whilst in hospital. It is scalable across the whole patient community to support cognitive health. It can also be deployed in secondary care environments to support in-patient stays, occupational therapy and rehabilitation patients; and be recommended for use to patients entering step-down-care into the community, e.g. oncology and critical care.
 
The App also provides carers and professionals with personalised reports showing the cognitive health of individuals and of patient cohorts vs the general population, alerts on patients at risk and progression over time. We recommend patients and their family members/carers also use the App to encourage social interaction and shared experiences.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Wellness and prevention of illness / Digital health / Person centred care
Benefit to NHS:
MyCognition offers a self-care digital solution to assess, monitor and treat mental health and well-being by addressing a person’s cognitive health. The MyCognition App improves cognitive function in as little as eight weeks and improves mental resilience and mental health symptoms across a range of mental health disorders. From studies with patients with conditions, such as Depression, Anxiety, Schizophrenia, Post-traumatic Stress Disorder, as well as Parkinson’s and cancer-related cognitive impairment.
 
MyCognition is a self-care solution that patients can use remotely in their everyday lives to help address their mental well-being. It is ideal for use in patient waiting to be refereed to NHS services where is there is extended waiting time. It is also suitable for patients in residential stay. It is scalable across the whole patient community to support cognitive health in a range of disease areas. It can also be deployed in secondary care environments to support in-patient stays, occupational therapy and rehabilitation patients; and be recommended for use to patients entering step-down-care into the community, e.g. oncology and critical care.
 
Evidence
MyCognition has led five years of research in clinics and local institutions, demonstrating the validity of the assessment and training paradigms adopted and the positive outcomes on users’ cognition, mental health, and consequent quality of life. MyCognition is collaborating with major international universities and clinics, such as Amsterdam Medical Centre (NL), Maastricht UMC+ (NL), UZA Antwerp (BE), McGill University (CA), UCL and the Royal Free Hospital Children’s School in London. We are running studies with patients with different mental health conditions, such as Depression, Anxiety, Schizophrenia, Post-traumatic Stress Disorder, as well as Parkinson’s disease and cancer-related cognitive impairment.
Initial Review Rating
4.00 (2 ratings)
Benefit to WM population:
MyCognition is committed to preventing and treating mental illness. Our strategy is aligned with the West Midlands Mental Health Strategy Boards recommendations in its 2017 report ‘Getting It Right First Time’ Prevention of Mental Illness. 
The 2017 Report by the West Midlands Mental Health Commission states that over 25% of the West Midlands population is suffering from mental illness. It highlights that people with an increased risk of developing mental health problems and/or for whom access to effective help is problematic are:
  • Unemployed people
  • People with long-term physical health conditions
  • Carers
  • Young children of school age*
  • Homeless people and people living in poor quality housing
  • People from Black, Asian and Minority Ethnic communities - Lesbian, Gay, Bisexual and Trans people
  • People with disabilities, including learning difficulties and sensory impairments
  • Young people leaving care
  • Survivors of sexual, emotional and physical abuse
  • People experiencing severe and multiple disadvantage.
*50% of mental health problems start before the age of 14 and 75% before 18
The aggregate economic and social cost of mental health problems in the WMCA is estimated at around £12.6 billion in 2014–15, equivalent to a cost of about £3,100 per head. With 28% being directly attributed to care costs of the NHS and Social Services costs. The employment costs are rising and equate to £4 billion per annum with human cost accounting for £5 billion. 
MyCognition have designed its technology to be integrated with NHS healthcare, social care, educational and workplace systems to help provide accessible self-care support for populations across the West Midlands. We wish to work with stakeholders to ensure there are as many community touchpoints for MyCognitions as possible. And provide adequate prevention and triage for at risk populations so they can reduce their risk of mental health development and deterioration.
MyCognition offers low cost personalised support to help these people deal with their mental illness. Offering them the opportunity to self-care, manage and reduce their symptoms and avoid ‘crashing’ in to the NHS for more serious and costly intervention. And more importantly lead productive and fulfilled lives.
Current and planned activity: 
Current:
MyCognition is working with several AHSNs evaluating the App in various clinical scenarios & patient pathways (rep. early 2019). Plans to roll out these clinical models with AHSNs’ support across the NHS.
 
Engaged in NHS test bed wave 2 programme and in discussions to test suitability for addressing mental health & wellbeing in schools, supporting referral to CAMS and adult mental health services, treatment of medically unexplained symptoms & diabetic self-care.
 
Running UK studies with NIHR, extending evidence base for MyCognition and also contributing to the global evidence base linking cognitive, physical & mental health.

Required:
Wish to test App & Platform’s performance in several clinical settings & pathways with West Mids. partners to generate additional data & build successful business models for NHS
  • like assistance with Procurement/Adoption & contracting with CCGs
  • further studies, seeking research partners to assist in NIHR funding proposals
What is the intellectual property status of your innovation?:
MyCognition is unique in the market place. We have full copyright of the code written for the app.

MHRA CE Marked Medical Device
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Innovation 'Elevator Pitch':
TPT is a new delivery platform for CBT offering easily accessible pre-recorded therapy sessions using a customised interactive phone system. Patients call TPT free - anytime, anywhere. Healthcare providers reduce treatment costs & cut waiting lists
Overview of Innovation:
TPT is a personalised, guided self-help psychological therapy delivered over the telephone in a range of pre-recorded modules for the treatment of mild to moderate anxiety-based mental health problems. It uses modern telephone technology to achieve vastly reduced costs with no waiting lists and is designed for use in NHS primary or secondary care settings.

Easy to prescribe, easy to use
TPT is available 'on prescription' to patients from their GP or other healthcare provider. The therapy can then be regularly accessed by the service-user making a simple free telephone call. An interactive, intelligent computer controlled telephone system using voice recordings of therapeutic scripts and questionnaires will then guide the service-user through a psycho-education, treatment and recovery programme that is responsive to the patient's individual presentation and circumstances. Patients will typically complete the programme in 8 to 12 weeks.
Instant access
Psycho-education, guidance and structured self-help for managing their condition are available to service-users wherever they are and at all times of the day and night. This immediacy of access is of particular benefit to patients with conditions that require help managing situational responses to emotional and environmental triggers or developing and maintaining impulse control strategies.
 
Choice of treatment modules for different presentations
A range of TPT modules is available for the treatment of different mild to moderate anxiety-based mental health problems such as generalised anxiety disorder, OCD and agoraphobia. Although each module is written with the specific presentation in mind there is a broad commonality of structure. A typical TPT module will have some of the following elements delivered by spoken scripts and using targeted questionnaires:
  • Introduction to anxiety and its effects
  • Description of the symptoms and causes
  • Psycho educational quizzes and self assessment measures
  • A range of anxiety management strategies
  • Instant-access session for managing acute symptoms
  • Cognitive techniques for overcoming negative thinking
  • Text messages which are sent to service-users to give feedback, reinforcement and reminders
  • Tailored sessions to inform and support friends and family
For a quick introduction to TPT, its operation and its benefits visit our 3 minute video at: https://vimeo.com/145905041
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Lower costs
  • TPT costs are 80% less than the cost of a course of therapy by a psychological wellbeing practitioner
  • No need for staff training or regular patient supervision by a therapist
  • No extra capital investment
  • Secondary prevention reduces need for further treatment
  • Reduction in demand for consultations by 'revolving door' patients
Instant access
  • Presenting service-users can leave the consulting room with a prescription giving immediate access to a suitable treatment offered in the 'language of their thoughts'.
  • Ease of use – familiar telephone dial in system for patients to access the session they require.
  • Help is available 24/7 whenever the patient needs support
Cuts waiting lists
  • High-level IAPT and secondary care services are freed up for more seriously ill service-users
Reduced dependency
  • Opportunity to reduce risk and cost of service-user dependency on prescription drugs
Reduced benefits bill
  • Patients can get back to work without deteriorating on a waiting list for other treatments
Fully translatable for the BAME community:
  • TPT modules can be translated once and used by many, reducing the cost for conventional translators
Meeting the Government agenda
In the face of growing numbers of people with common mental health problems and in an environment of increasing costs and reduced budgets the Government is directing commissioners to look for new ways of improving accessibility to treatment. TPT falls in line with many of these objectives, such as:
  • Cost reductions in the NHS
  • Increased patient choice
  • Flexible delivery of services
  • Access by minority groups
  • Use of new technology
  • Innovation programmes
Quality Assurance
The Cognitive Behavioural Therapy delivered by TPT is well researched, evidence-based, and commonly practiced in the NHS. The therapy scripts have been peer reviewed. The technology of the delivery platform has been exhaustively tested to ensure reliable operation in the face of intensive and unpredictable use.

Performance metrics
Standard reports showing patient outcome and experience measures are available from the database which manages TPT. Healthcare providers can monitor their consumption of TPT licences. Cornard Healthcare is happy to work with clients on their reporting requirements in the light of user experience.
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
Prevention of Mental Health Problems
We believe that TPT can address the needs identified under the ‘Prevention of Mental Health Problems’ campaign. It is a simple, easy-to-use delivery platform which gives patients with mild to moderate mental health problems instant access to CBT and gives healthcare providers a cost-effective and flexible treatment option.
TPT is designed to teach people coping strategies for mild to moderate mental health problems. This, in turn, will improve the lives of the friends and family who are supporting them.
Using TPT in a primary care setting such as the Sandwell Model will reduce the burden on GPs and, by improving access to cost-effective treatment, will improve the mental health of the population. With only a few mouse-clicks during a consultation, GPs and other healthcare professionals log in online, prescribe a unit of TPT and print a simple two-page user-guide for the patient to take away.
The modular nature of TPT means it can be tailored to the needs of the population across the West Midlands, thus reducing the number of people directly and indirectly affected by mental health problems. Cornard Healthcare can work with healthcare providers and with commissioners to develop modules to best address the specific needs of the region.
The confidentiality of the TPT delivery platform for CBT and its ready translatability make it specially well suited to the diverse multi-ethnic and multi-cultural population groups in the West Midlands where language barriers and the stigma associated with mental health problems can prevent  patients from accessing the services they need.
Patient data protection
There is no personal data stored within the system as all patients are only referenced via their unique ID number.
Delivery Costs
The cost to the prescribing healthcare organisation is in two parts:
  • The prescribing licence for the organisation
  • A service-user licence for each 12 week course of treatment. These are pre-purchased in blocks by healthcare organisations.
Cornard Healthcare is happy to discuss favourable terms for early-adoption sites.
Patient Cost - None
TPT is free at the point of use. There is no cost to the patient as this covered by the service-user licence, so those on low income or benefits do not need to use valuable mobile credit or incur large telephone bills.
Current and planned activity: 
Cornard Healthcare is currently working with MIND in Suffolk who are using the TPT system to help their clients. The pilot study has already shown the system to be easily accepted and used by patients, popular with clinicians and reliable in use.

Required activity:
  • Procurement / Adoption of TPT across the West Midlands Trusts within both primary and secondary care settings
  • Feedback from clinicians and patients on how to develop the service to best suit the needs of patients and providers


 
What is the intellectual property status of your innovation?:
IP held and owned by Cornard Healthcare Limited.
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
0
0
Votes
-99999

Created by

Share and Follow